{"nct_id":"NCT01802879","title":"Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Continue to Benefit From the Treatment as Judged by the Investigator","status":"COMPLETED","status_verified_date":"2019-11","start_date":"2013-06-24","start_date_type":"ACTUAL","primary_completion_date":"2018-11-19","primary_completion_date_type":"ACTUAL","completion_date":"2018-11-19","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}